Effectdossier · gearchiveerd kwartaal
AVIR
Atea Pharmaceuticals, Inc. · Healthcare · Biotechnology
17Gevolgde houders
+2Δ houders
27.75MGehouden aandelen
$80.49MGerapporteerde waarde
+2Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +13.3% ·
aandelenstroom +1.2% ·
netto nieuwe posities +11.8%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | -4 | 39.30M | $182.78M | +3 | −7 |
| Q1 2026 | 68 | +5 | 39.11M | $209.92M | +8 | −3 |
| Q4 2025 | 63 | +1 | 37.55M | $134.03M | +1 | — |
| Q3 2025 | 17 | +2 | 27.75M | $80.49M | +2 | — |
| Q2 2025 | 12 | 0 | 25.41M | $91.49M | +1 | −1 |
| Q1 2025 | 9 | -1 | 6.11M | $18.26M | — | −1 |
| Q4 2024 | 10 | +1 | 6.07M | $20.35M | +2 | −1 |
| Q3 2024 | 8 | 0 | 4.57M | $15.30M | +1 | −1 |
| Q2 2024 | 8 | — | 4.70M | $15.57M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 5.82M | +1.8% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 5.82M | +1.8% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 5.82M | +1.8% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 4.71M | -3.6% | $13.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 4.71M | -3.6% | $13.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 4.71M | -3.6% | $13.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 1.90M | -1.3% | $5.51M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 1.90M | -1.3% | $5.51M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passief) | 1.78M | +0.4% | $5.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 1.23M | -0.5% | $3.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Millennium Management ✦ | 487.22K | +179.2% | $1.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 471.29K | +28.6% | $1.37M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 364.77K | +86.2% | $1.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 364.77K | +86.2% | $1.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 340.14K | — | $986,406 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 340.14K | — | $986,406 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Wellington Management ✦ | 262.77K | -26.9% | $762,048 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | Wellington Management ✦ | 262.77K | -26.9% | $762,048 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 44 | Wellington Management ✦ | 262.77K | -26.9% | $762,048 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 97.53K | +22.1% | $283,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | Marshall Wace ✦ | 87.06K | +250.1% | $252,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | Marshall Wace ✦ | 87.06K | +250.1% | $252,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 41.73K | Nieuw | $121,014 | 0.0% | New | 1 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 13.41K | Nieuw | $38,889 | 0.0% | New | 1 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 13.41K | Nieuw | $38,889 | 0.0% | New | 1 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 13.41K | Nieuw | $38,889 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $121,014 | 0.0% |
| AQR Capital Management | $38,889 | 0.0% |
| AQR Capital Management | $38,889 | 0.0% |
| AQR Capital Management | $38,889 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 126 houders, 59.16M aandelen, $308.71M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API